Quantification of Osteopontin in Human Plasma With an ELISA: Basal Levels in Pre- and Postmenopausal Women

Objectives: To develop an immunoassay for osteopontin (OPN), a secreted phosphoglycoprotein that is implicated in a number of human diseases, and establish basal plasma OPN levels in healthy women. Design and Methods: An antigen-capture ELISA was developed to quantify OPN in plasma using a combination of mouse monoclonal and rabbit polyclonal antibodies. Basal OPN levels were determined in blood plasma of 21 pre- and 14 postmenopausal women obtained at 7-day intervals over a 4-week period. Results: A group of 35 healthy women had a median OPN level of 31 μg/L (range = 14-64 μg/L). Comparison between pre- and post-menopausal women showed that their 4-week average OPN levels did not differ significantly (p> 0.16, Mann-Whitney test), and that levels in each premenopausal individual remained constant during the menstrual cycle, unaffected by cyclical levels of leuteinizing hormone and progesterone. Conclusion: Systematic quantification of plasma OPN can now be done by ELISA, which was used to establish basal plasma OPN levels in a group of healthy women. Levels in pre- and postmenopausal women appeared relatively stable over a 4-week period.